Randall Moreadith

Chief Scientific Officer, Serina Therapeutics, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$0.4M

Companies

Latest trade

Mar 23, 2026

Companies

Serina Therapeutics, Inc.Chief Scientific Officer −$0.5M

Trades

SER Sold 6,500 shares at $2.86 · planned $0.0M Mar 23

SER Sold 39,000 shares at $2.50 · planned $0.1M Mar 19

SER Sold 6,500 shares at $3.03 · planned $0.0M Feb 2

SER Sold 6,500 shares at $3.57 · planned $0.0M Jan 28

SER Sold 2,500 shares at $2.95 · planned $0.0M Jan 22

SER Sold 2,000 shares at $3.00 · planned $0.0M Jan 21

SER Sold 2,000 shares at $3.07 · planned $0.0M Jan 20

SER Sold 1,084 shares at $2.50 · planned $0.0M Jan 14

SER Sold 5,416 shares at $2.50 · planned $0.0M Jan 13

SER Sold 13,000 shares at $2.69 · planned $0.0M Jan 8

SER Sold 4,100 shares at $2.60 · planned $0.0M Dec 23

SER Sold 5,673 shares at $2.67 · planned $0.0M Dec 22

SER Sold 3,227 shares at $2.96 · planned $0.0M Dec 16

SER Sold 1,700 shares at $3.26 · planned $0.0M Dec 12

SER Sold 3,555 shares at $3.24 · planned $0.0M Dec 11

SER Sold 645 shares at $3.35 · planned $0.0M Dec 10

SER Sold 600 shares at $3.31 · planned $0.0M Dec 9

SER Sold 5,000 shares at $3.52 · planned $0.0M Dec 3

SER Sold 1,500 shares at $3.91 · planned $0.0M Dec 2

SER Sold 5,965 shares at $3.90 · planned $0.0M Nov 25

SER Sold 535 shares at $3.94 · planned $0.0M Nov 24

SER Sold 6,500 shares at $3.75 · planned $0.0M Nov 18

SER Sold 6,500 shares at $4.10 · planned $0.0M Nov 10

SER Sold 3,398 shares at $4.24 · planned $0.0M Nov 5

SER Sold 3,102 shares at $4.40 · planned $0.0M Nov 4

SER Sold 5,551 shares at $4.96 · planned $0.0M Oct 28

SER Sold 949 shares at $5.19 · planned $0.0M Oct 27

SER Sold 6,500 shares at $4.97 · planned $0.0M Oct 20

SER Sold 4,326 shares at $5.20 · planned $0.0M Oct 13

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.